WSJ News Exclusive | Novartis in Advanced Talks to Buy Cytokinetics

[ad_1] Updated Jan. 8, 2024 1:14 pm ET Novartis is close to clinching an acquisition of Cytokinetics and its promising heart drug, as big pharmaceutical companies continue to snap up…